Physician

Nicholas Oswald Iannotti, MD, FACP

According to 2025 Medicare claims, Nicholas Iannotti, MD, FACP (NPI: 1154360642) practices hematology/oncology in the Port St. Lucie, FL market, with the plurality of this provider's patient population coming from St. Lucie, FL. This provider's primary affiliated billing organization is HEM ONC ASSOCIATES OF THE TREASURE COAST, PA (NPI: 1205882867; TIN: 650696665) and primary practice location at 34996-3349.

Iannotti's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,311 traditional Medicare patients, billed 331,938 HCPCS/CPT codes, and received $5,560,270 in Medicare payments. The top billing code was 99213 (Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more). Part D data shows 2,770 prescription claims across 493 beneficiaries totaling $8,091,572 in drug costs, led by Imbruvica (Ibrutinib). 2023 DME data shows 46 claims. Open Payments data shows 82 records totaling $67,464. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $2,733,151 to $5,560,270. Similarly, Part D prescription costs have risen steadily, from $1,473,030 to $8,091,572. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $6,712 and ending at $1,440.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,623	401,699	$2,733,151
2016	1,801	511,848	$3,641,032
2017	1,741	489,874	$4,104,923
2018	1,684	354,898	$4,182,577
2019	1,630	430,323	$4,916,739
2020	1,532	499,946	$6,152,219
2021	1,422	384,208	$4,954,156
2022	1,382	363,039	$4,790,556
2023	1,297	309,008	$4,626,460
2024	1,311	331,938	$5,560,270

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	394	2,006	$1,473,030
2016	449	2,253	$2,340,208
2017	425	2,441	$3,645,927
2018	455	2,209	$4,090,941
2019	466	2,348	$4,436,600
2020	517	2,925	$5,674,174
2021	451	2,505	$5,333,862
2022	481	2,259	$5,501,817
2023	486	2,254	$5,464,614
2024	493	2,770	$8,091,572

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	13	125	$53,487
2016	22	242	$57,298
2017	N/R	37	$1,456
2018	N/R	11	$2,915
2019	N/R	N/R	N/R
2020	N/R	22	$1,439
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	46	$9,292
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	686	2,085	$69
82378	Carcinoembryonic antigen (cea) protein level	344	881	$19
80053	Blood test, comprehensive group of blood chemicals	750	2,244	$10
36415	Insertion of needle into vein for collection of blood sample	873	2,767	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	946	3,722	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Imbruvica	Ibrutinib	140	4,076	$2,147,592
Xtandi	Enzalutamide	70	2,100	$975,862
Lenalidomide	Lenalidomide	48	1,344	$700,335
Pomalyst	Pomalidomide	31	861	$695,078
Ibrance	Palbociclib	29	812	$460,784

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	16	$487	Tempus AI, Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	66	$66,978	Epizyme, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Nicholas Oswald Iannotti, MD, FACP?

Tedicare shows public-source Medicare data for Nicholas Oswald Iannotti, MD, FACP (NPI 1154360642), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Nicholas Oswald Iannotti, MD, FACP have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Nicholas Oswald Iannotti, MD, FACP?

Nicholas Oswald Iannotti, MD, FACP is linked to HEM ONC ASSOCIATES OF THE TREASURE COAST, PA (billing NPI 1205882867) in the available physician profile data.

Does Nicholas Oswald Iannotti, MD, FACP have Open Payments data?

Nicholas Oswald Iannotti, MD, FACP has 82 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.